CWM
ATOS icon

Concert Wealth Management’s Atossa Therapeutics ATOS Stock Holding History

Concert Wealth Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-27
Closed -$55K – 689
2015
Q3 		$55K Hold
27
– – 0.01% 684
2015
Q2 		$81K Buy
+27
New +$108K 0.01% 675

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
GBBWRPM
Genovese Burford & Brothers Wealth & Retirement Plan Management Sacramento, California $400M AUM 14.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Concert Wealth Management's ATOS Position: Q4 2015 in Review

Concert Wealth Management sold out of Atossa Therapeutics (ATOS) in Q4 2015, closing a stake of 27 shares — an estimated $55K sold.

Concert Wealth Management first reported a position in ATOS in Q2 2015 and held it in 2 quarters. The position peaked at $81K in Q2 2015. 17 funds tracked by Wall St. Rank hold ATOS as of Q4 2015.

  • Concert Wealth Management reported no remaining Atossa Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Concert Wealth Management sold 27 Atossa Therapeutics shares in Q4 2015, an estimated $55K.
  • Concert Wealth Management first reported a position in Atossa Therapeutics in Q2 2015 and held it in 2 quarters.
  • Concert Wealth Management's Atossa Therapeutics position peaked at $81K in Q2 2015.
  • 17 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2015.

Based on Concert Wealth Management's 13F filing for Q4 2015, filed 9 Feb 2016.